- Home
- MYFW vs STTK Comparison
MYFW vs STTK Comparison
Compare MYFW & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYFW
- STTK
- Stock Information
- Founded
- MYFW 2002
- STTK 2016
- Country
- MYFW United States
- STTK United States
- Employees
- MYFW N/A
- STTK N/A
- Industry
- MYFW Major Banks
- STTK Biotechnology: Pharmaceutical Preparations
- Sector
- MYFW Finance
- STTK Health Care
- Exchange
- MYFW Nasdaq
- STTK Nasdaq
- Market Cap
- MYFW 169.4M
- STTK 173.6M
- IPO Year
- MYFW 2018
- STTK 2020
- Fundamental
- Price
- MYFW $19.51
- STTK $3.74
- Analyst Decision
- MYFW Buy
- STTK Strong Buy
- Analyst Count
- MYFW 3
- STTK 3
- Target Price
- MYFW $20.67
- STTK $10.67
- AVG Volume (30 Days)
- MYFW 21.2K
- STTK 129.3K
- Earning Date
- MYFW 10-17-2024
- STTK 11-07-2024
- Dividend Yield
- MYFW N/A
- STTK N/A
- EPS Growth
- MYFW N/A
- STTK N/A
- EPS
- MYFW 0.36
- STTK N/A
- Revenue
- MYFW $80,146,000.00
- STTK $4,123,999.00
- Revenue This Year
- MYFW N/A
- STTK $164.45
- Revenue Next Year
- MYFW $11.04
- STTK N/A
- P/E Ratio
- MYFW $55.41
- STTK N/A
- Revenue Growth
- MYFW N/A
- STTK 380.09
- 52 Week Low
- MYFW $12.84
- STTK $1.33
- 52 Week High
- MYFW $21.15
- STTK $11.76
- Technical
- Relative Strength Index (RSI)
- MYFW 57.61
- STTK 52.85
- Support Level
- MYFW $19.58
- STTK $3.60
- Resistance Level
- MYFW $20.42
- STTK $3.82
- Average True Range (ATR)
- MYFW 0.59
- STTK 0.23
- MACD
- MYFW 0.05
- STTK 0.03
- Stochastic Oscillator
- MYFW 59.73
- STTK 64.91
About MYFW First Western Financial Inc.
First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.